104 related articles for article (PubMed ID: 10794812)
1. Pharmacological characterization of the cloned neuropeptide Y y(6) receptor.
Mullins DE; Guzzi M; Xia L; Parker EM
Eur J Pharmacol; 2000 Apr; 395(2):87-93. PubMed ID: 10794812
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors.
Schober DA; Gackenheimer SL; Heiman ML; Gehlert DR
J Pharmacol Exp Ther; 2000 Apr; 293(1):275-80. PubMed ID: 10734179
[TBL] [Abstract][Full Text] [Related]
3. Blunted pancreatic polypeptide-induced vasodilatation in mesenteric resistance vessels from spontaneously hypertensive rats.
Gradin KA; Li JY; Zhu H; Simonsen U
Eur J Pharmacol; 2008 Dec; 601(1-3):118-23. PubMed ID: 18851959
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y Y(1) receptor regulates protein turnover and constitutive gene expression in hypertrophying cardiomyocytes.
Nicholl SM; Bell D; Spiers Jp; McDermott BJ
Eur J Pharmacol; 2002 Apr; 441(1-2):23-34. PubMed ID: 12007917
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y-induced contraction is mediated by neuropeptide Y Y2 and Y4 receptors in the rat colon.
Pheng LH; Perron A; Quirion R; Cadieux A; Fauchère JL; Dumont Y; Regoli D
Eur J Pharmacol; 1999 Jun; 374(1):85-91. PubMed ID: 10422644
[TBL] [Abstract][Full Text] [Related]
6. The neuropeptide Y Y1 receptor selective radioligand, [125I][Leu31,Pro34]peptide YY, is also a high affinity radioligand for human pancreatic polypeptide 1 receptors.
Gehlert DR; Gackenheimer SL; Schober DA; Beavers L; Gadski R; Burnett JP; Mayne N; Lundell I; Larhammar D
Eur J Pharmacol; 1996 Dec; 318(2-3):485-90. PubMed ID: 9016942
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y (NPY) and peptide YY (PYY) effects in the epididymis of the guinea-pig: evidence of a pre-junctional PYY-selective receptor.
Haynes JM; Hill SJ; Selbie LA
Br J Pharmacol; 1997 Dec; 122(7):1530-6. PubMed ID: 9421306
[TBL] [Abstract][Full Text] [Related]
8. GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y Y1 receptor antagonists and neuropeptide Y Y4 receptor agonists.
Parker EM; Babij CK; Balasubramaniam A; Burrier RE; Guzzi M; Hamud F; Mukhopadhyay G; Rudinski MS; Tao Z; Tice M; Xia L; Mullins DE; Salisbury BG
Eur J Pharmacol; 1998 May; 349(1):97-105. PubMed ID: 9669502
[TBL] [Abstract][Full Text] [Related]
9. Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226.
Wieland HA; Willim KD; Entzeroth M; Wienen W; Rudolf K; Eberlein W; Engel W; Doods HN
J Pharmacol Exp Ther; 1995 Oct; 275(1):143-9. PubMed ID: 7562543
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands.
Ziemek R; Brennauer A; Schneider E; Cabrele C; Beck-Sickinger AG; Bernhardt G; Buschauer A
Eur J Pharmacol; 2006 Dec; 551(1-3):10-8. PubMed ID: 17027743
[TBL] [Abstract][Full Text] [Related]
11. [D-Trp(34)] neuropeptide Y is a potent and selective neuropeptide Y Y(5) receptor agonist with dramatic effects on food intake.
Parker EM; Balasubramaniam A; Guzzi M; Mullins DE; Salisbury BG; Sheriff S; Witten MB; Hwa JJ
Peptides; 2000 Mar; 21(3):393-9. PubMed ID: 10793222
[TBL] [Abstract][Full Text] [Related]
12. The dog saphenous vein: a sensitive and selective preparation for the Y2 receptor of neuropeptide Y.
Pheng LH; Fournier A; Dumont Y; Quirion R; Regoli D
Eur J Pharmacol; 1997 May; 327(2-3):163-7. PubMed ID: 9200555
[TBL] [Abstract][Full Text] [Related]
13. Human neuropeptide YY1 receptors exert unequal control of the extracellular acidification rate in different cell lines.
Van Liefde I; Vanderheyden PM; Fraeyman N; De Backer JP; Vauquelin G
Eur J Pharmacol; 1998 Apr; 346(1):87-95. PubMed ID: 9617757
[TBL] [Abstract][Full Text] [Related]
14. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
Iyengar S; Li DL; Simmons RM
J Pharmacol Exp Ther; 1999 May; 289(2):1031-40. PubMed ID: 10215684
[TBL] [Abstract][Full Text] [Related]
15. Non-competitive binding of the nonpeptide antagonist BIBP3226 to rat forebrain neuropeptide Y1 receptors.
Vanderheyden PM; Van Liefde I; De Backer JP; Vauquelin G
Eur J Pharmacol; 1997 Jul; 331(2-3):275-84. PubMed ID: 9274990
[TBL] [Abstract][Full Text] [Related]
16. Labeling of neuropeptide Y receptors in SK-N-MC cells using the novel, nonpeptide Y1 receptor-selective antagonist [3H]BIBP3226.
Entzeroth M; Braunger H; Eberlein W; Engel W; Rudolf K; Wienen W; Wieland HA; Willim KD; Doods HN
Eur J Pharmacol; 1995 May; 278(3):239-42. PubMed ID: 7589160
[TBL] [Abstract][Full Text] [Related]
17. The rabbit ileum: a sensitive and selective preparation for the neuropeptide Y Y5 receptor.
Pheng LH; Quirion R; Iyengar S; Fournier A; Regoli D
Eur J Pharmacol; 1997 Aug; 333(2-3):R3-5. PubMed ID: 9314048
[TBL] [Abstract][Full Text] [Related]
18. Potent neuropeptide Y Y1 receptor antagonist, 1229U91: blockade of neuropeptide Y-induced and physiological food intake.
Kanatani A; Ishihara A; Asahi S; Tanaka T; Ozaki S; Ihara M
Endocrinology; 1996 Aug; 137(8):3177-82. PubMed ID: 8754736
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of glucose stimulated insulin secretion by neuropeptide Y is mediated via the Y1 receptor and inhibition of adenylyl cyclase in RIN 5AH rat insulinoma cells.
Morgan DG; Kulkarni RN; Hurley JD; Wang ZL; Wang RM; Ghatei MA; Karlsen AE; Bloom SR; Smith DM
Diabetologia; 1998 Dec; 41(12):1482-91. PubMed ID: 9867216
[TBL] [Abstract][Full Text] [Related]
20. Identification of potent and selective neuropeptide Y Y(1) receptor agonists with orexigenic activity in vivo.
Mullins D; Kirby D; Hwa J; Guzzi M; Rivier J; Parker E
Mol Pharmacol; 2001 Sep; 60(3):534-40. PubMed ID: 11502885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
